BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 22838247)

  • 1. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
    J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
    Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
    J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary.
    Szigetvári I; Szepesi J; Végh G; Bátorfi J; Arató G; Gáti I; Berkowitz RS; Fülöp V
    J Reprod Med; 2006 Oct; 51(10):841-8. PubMed ID: 17086814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Berkowitz RS
    J Reprod Med; 2014; 59(5-6):227-34. PubMed ID: 24937962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
    Cagayan MS
    J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 16. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
    J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
    Cagayan MS; Lu-Lasala LR
    J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
    Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB
    Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.